Pre-market Hot Trades in US Stocks
Urban-Gro, up 9.86% in pre-market trading, has no significant recent news. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
QuantumScape is up 7.01% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 16, QuantumScape closed in the green for two consecutive days, with increased trading volume during the day, and enthusiasm for new energy is high. Short-term capital inflow in the community has led the stock price to break through the $6.8 level, with a high discussion atmosphere post-market. It is expected that short-term trading volume will continue to expand, and the stock price is likely to challenge a new level of $7.1-$7.5. Source: Zhitong Finance
</li>
<li>
On December 16, QuantumScape traded sideways at a low level, with reduced trading volume. Affected by the failure of upstream raw material price reductions, capital in the sector is cautious, and technical indicators show overselling, with community attention on trading volume anomalies. Source: Zhitong Finance
</li>
<li>
On December 16, QuantumScape director Dipender Saluja reported the sale of common stock, involving 3.29 million shares at a price of $11.20, with a total value of approximately $36.94 million. Source: SEC announcement. The new energy sector has seen increased volatility, with significant capital inflow.
</li>
</ol>
Top Gainers in Pre-market US Stocks
cbdMD, up 45.45% in pre-market trading, has no significant recent news. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Agape ATP is up 43.89% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 17, Agape ATP announced it will continue to focus on the diversified development of health and sustainable green energy businesses to provide sustainable equity performance value. This move may enhance investor confidence and drive the stock price up. Source: Benzinga
</li>
<li>
On December 17, Agape ATP's third-quarter revenue fell to $370,590, down from $465,500 in the second quarter, while the loss per share remained at $0.01. Despite weak financial performance, market expectations for the company's future strategy may drive the stock price up. Source: Benzinga
</li>
<li>
On December 17, Benzinga's stock ranking showed that ATPC stock has a negative price trend across all time frames. However, recent strategic adjustments may change market expectations, leading to a rebound in the stock price. Source: Benzinga. The health and green energy industry has been active recently.
</li>
</ol>
DBV Technologies is up 36.26% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 16, DBV Technologies announced that its drug VIASKIN for treating peanut allergy in children met its primary endpoint in Phase III trials, causing the stock price to soar nearly 70%. The trial results showed that 46.6% of children responded to the drug within 12 months, compared to only 14.8% in the placebo group
The company plans to submit a biologics license application in the first half of 2026. Source: MT Newswires
</li>
<li>
On December 17, the FDA previously granted breakthrough therapy designation to VIASKIN, and DBV Technologies expects to submit a biologics license application in the first half of 2026, potentially receiving priority review. Source: WSJ
</li>
<li>
On December 17, ABSA and BS warrants are now exercisable, potentially bringing the company up to €168.2 million in funding. As of September 30, 2025, the company's cash balance was $69.8 million, expected to sustain operations until the third quarter of 2026. Source: RTT News The biotechnology industry has recently performed strongly, with significant capital inflows
</li>
</ol>

UGRO

Urban-Gro pre-market up 9.86%; QuantumScape pre-market up 7.01%; cbdMD pre-market up 45.45%; Agape ATP pre-market up 43.89%; DBV Technologies pre-market up 36.26%

Pre-market hot trades in US stocks: Urban-Gro up 9.86% in pre-market; QuantumScape up 7.01% in pre-market